Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Targeting Apoptosis Pathways in Cancer Therapy

Author(s): Simone Fulda and Klaus-Michael Debatin

Volume 4 , Issue 7 , 2004

Page: [569 - 576] Pages: 8

DOI: 10.2174/1568009043332763

Price: $65

Abstract

Killing of tumor cells by anticancer therapies commonly used in the treatment of cancer, e.g. chemotherapy, γ-irradiation, immunotherapy or suicide gene therapy, is predominantly mediated by triggering apoptosis, the cells intrinsic death program. Accordingly, defects in apoptosis pathways can result in cancer resistance to current treatment approaches. Understanding the molecular mechanisms that regulate cell death programs including apoptosis, and how resistant forms of cancer evade apoptotic events, may provide novel opportunities for cancer drug development.

Keywords: apoptosis, cancer, mitochondria, cancer therapy, resistance


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy